Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report

Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report

Primary liver cancer (PLC) that originates in the liver is a malignant tumor with the worst prognosis. Hepatocellular carcinoma (HCC) is the most common type of PLC. Most PLC cases are diagnosed at advanced stages mainly due to their insidious onset and rapid progression. Patients with PLC undergo s...

Full description

Bibliographic Details
Main Authors: Yun Wang, Yan Zhao, Miaoling Li, Huilian Hou, Zhijie Jian, Weizhi Li, Peijie Li, Fuquan Ma, Mengying Liu, Haibo Liu, Hui Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
primary liver cancer (PLC)
hepatocellular carcinoma (HCC)
chimeric antigen receptor T cell (CAR-T)
AFP
immunotherapy
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1180001/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1180001/full

Similar Items